Darling Ingredients’ Health Brand Rousselot Receives U.S. Patent for Nextida® GC, the First Collagen Peptide Composition Supporting Blood Glucose Regulation
“This patent reinforces the scientific foundation behind Nextida GC and highlights Darling Ingredients’ ability to translate its collagen expertise into targeted health solutions,” said
Nextida GC is a collagen peptide composition formulated for dietary supplement applications related to natural glucose control and metabolic support. It is part of an expanding portfolio of collagen products being developed to address distinct functional health needs.
For more information about Nextida GC and Rousselot’s portfolio of science-backed collagen solutions, visit rousselot.com.
About
About Darling Ingredients
A pioneer in circularity, Darling Ingredients Inc. (NYSE: DAR) takes material from the animal agriculture and food industries, and transforms them into valuable ingredients that nourish people, feed animals and crops, and fuel the world with renewable energy. The company operates over 260 facilities in more than 15 countries and processes about 15% of the world’s animal agricultural by-products, produces about 30% of the world’s collagen (both gelatin and hydrolyzed collagen), and is one of the largest producers of renewable energy. To learn more, visit darlingii.com. Follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260602818463/en/
Darling Ingredients Contacts
M
edia: Jillian Fleming
Director, Global Communications
(972) 541-7115; jillian.fleming@darlingii.com
Investors: Suann Guthrie
Senior VP, Investor Relations and Global Affairs
(469) 214-8202; suann.guthrie@darlingii.com
Source: Darling Ingredients Inc.